Research programme: selective androgen receptor modulators - Karo PharmaAlternative Names: SARMs - Karo Pharma/Radius
Latest Information Update: 21 Dec 2016
At a glance
- Originator Karo Bio
- Mechanism of Action Selective androgen receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Muscular atrophy; Osteoporosis
Most Recent Events
- 28 Feb 2008 Discontinued - Preclinical for Muscle wasting in USA (PO)
- 28 Feb 2008 Discontinued - Preclinical for Osteoporosis in USA (PO)
- 12 Sep 2006 Preclinical trials in Muscle wasting in USA (PO)